Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Working Capital Ratio

42.32%

Quarterly · Period ending: Jun 30, 2026

LCTX Working Capital Ratio

Latest reported42.32%period endingJun 30, 2026

Latest reported42.32%period endingJun 30, 2026

LCTX Quarterly Working Capital Ratio (96.15% → 42.32%)

Quarterly working capital ratio

High-resolution chart · PNG

LCTX working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Working Capital Ratio — Quarterly
Period ending	Working Capital Ratio
Jun 30, 2001	-56.8893%
Mar 31, 2001	60.1365%
Dec 31, 2000	64.4559%
Sep 30, 2000	84.0218%
Jun 30, 2000	79.3942%
Mar 31, 2000	90.2456%
Dec 31, 1999	84.6079%
Sep 30, 1999	88.5714%
Jun 30, 1999	92.8571%
Mar 31, 1999	94.6237%
Sep 30, 1998	81.5789%
Jun 30, 1998	80.4348%
Mar 31, 1998	82.1429%
Dec 31, 1997	86.5672%
Sep 30, 1997	81.8182%
Jun 30, 1997	83.1325%
Mar 31, 1997	97.4026%
Dec 31, 1996	93.3333%
Sep 30, 1996	88%
Jun 30, 1996	93.3333%
Sep 30, 1995	93.3333%
Jun 30, 1995	88.8889%
Mar 31, 1995	95.122%
Dec 31, 1994	98.3051%
Sep 30, 1994	96.3636%
Jun 30, 1994	98.3051%
Mar 31, 1994	98.4375%
Dec 31, 1993	92.8571%
Sep 30, 1993	100%
Jun 30, 1993	100%
Mar 31, 1993	97.4359%
Dec 31, 1992	97.561%
Sep 30, 1992	95.5556%
Jun 30, 1992	95.8333%
Mar 31, 1992	96.1538%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.